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Automatic control of gene expression in living cells is paramount importance to
characterise both endogenous gene regulatory networks and synthetic circuits. In ad-
dition, such a technology can be used to maintain the expression of synthetic circuit's
components in an optimal range, in order to ensure reliable performances. Here we
present a microﬂuidics-based method to automatically control gene expression from
the Tetracycline-inducible promoter in mammalian cells in real-time. Our approach is
based on the negative-feedback control engineering paradigm. We validated our method
in a monoclonal population of cells constitutively expressing a ﬂuorescent reporter pro-
tein (d2EYFP), downstream of a minimal CMV promoter with seven tet-responsive
operator motifs (CMV-TET ). These cells also constitutively express the Tetracycline-
transactivator protein (tTA). In cells grown in standard growth medium, tTA is able
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to bind the CMV-TET promoter causing d2EYFP to be maximally expressed. Upon
addition of Tetracycline to the culture medium, tTA detaches from the CMV-TET pro-
moter thus preventing d2EYFP expression. We tested two diﬀerent model-independent
control algorithms (relay and PI) to force a monoclonal population of cells to express
an intermediate level of d2EYFP equal to 50% of its maximum expression level, for
up to 3,500 minutes. The control input is either Tetracycline-rich or standard growing
medium. We demonstrated that both the relay and the PI controller can regulate gene
expression at the desired level, despite oscillations (dampened in the case of the PI)
around the chosen set-point.
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Biological systems control their functions in order to maintain homeostasis and respond to
endogenous and exogenous cues. In 1954, Fred Grodins and colleagues were among the ﬁrst
to describe a biological function, i.e. the regulation of CO2 by the respiratory system, in
terms of a feedback-control system, by drawing an analogy to an electric circuit (1 ). The
study of Molecular Biology from a Control Theory perspective has been, however, mostly
theoretical for the last 60 years, mainly because of a lack of quantitative measurements of
molecular processes. The advent of new technologies to quantitatively measure molecular
species and manipulate cells has now enabled practical applications of control engineering
to living systems.
Quantitative regulation of gene expression from inducible promoters in yeast cells, using
feedback-control strategies, has been recently demonstrated (24 ). The aim is to force a
population of cells, or even a single cell, to express a predetermined amount of a protein of
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interest, which can be either constant or time-varying, by automatically administering an
inducer molecule, light stimulus or environmental perturbation, to the cells harbouring an
inducible promoter.
In 2011, a semi-automated control strategy was implemented to regulate gene expression
in yeast from the GAL1 promoter, using a synthetic light-inducible transcription factor(2 ).
A more advanced fully automated strategy was described in 2012, to control the expression
of a reporter protein from the Hog1-responsive promoter using a microﬂudics platform (3 )
with osmotic pressure as control input. We reported the ﬁrst control strategy to regulate
gene expression from the GAL1 promoter using galactose and glucose as control inputs(4 )
by means of an ad-hoc microﬂuidic platform.
The application of control engineering to mammalian systems is still at its infancy. A pi-
oneering work was performed in 2011 by Toettcher and colleagues (5 ), where they described
an optogenetic approach to control the post-translational activation of the PI3K cascade
by automatically adjusting the light input to single cells in order to buﬀer for cell-to-cell
variability. However, to our knowledge, control of gene expression from inducible promoters
in mammalian cells has not been yet achieved.
Transcription in mammalian cells is up to one order of magnitude slower than in bacteria or
simple eukaryotes, therefore the time-scale involved in the control of gene expression are much
longer (days instead of hours) (6 ). Moreover, mammalian cells have much more stringent
requirements for culture conditions, such as temperature, pH, CO2 concentration, higher
sensitivity to photo-toxicity, which have to be taken into account in order to successfully
maintain a cell culture in a microﬂudics chamber over several days under a time-lapse mi-
croscope. These needs are a distinctive feature of mammalian cells that have so far hindered
the application of automatic control to mammalian systems.
In this work, we present a microﬂuidics-based feedback control strategy to quantita-
tively regulate gene expression from a Tetracycline-inducible promoter in mammalian cells.
We show that it is indeed possible to force a population of cells, harbouring the inducible
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promoter, to express a predetermined level of a protein of interest by automatically admin-
istering pulses of Tetracycline to the cells, whose duration is computed in real-time by a
control algorithm. The ability to express a protein of interest at diﬀerent levels, or in a time-
varying fashion, from the same promoter would be a unique tool for several applications,
including studying the eﬀects of gene dosage in disease, probing the function of endogenous
regulatory networks, and for synthetic biology applications.
Results and Discussion
Implementation of the control platform.
The control platform, described in Figure 1a, was set up to monitor in real-time ﬂuores-
cent protein levels and to provide time-varying concentrations of an inducer molecule. A
microﬂuidics device (7 ) was used to trap cells in a micro-metric chamber. Either culture
medium or an inducer molecule can be supplied to the chamber by changing the relative
heights between two syringes that are connected to it via capillary tubes, one containing just
culture medium and the other culture medium plus the inducer molecule. The ﬂuorescence
produced by cells (y) is imaged at regular sampling times of 15 min by the microscope, and
converted to a quantitative value (ym) via an image segmentation algorithm, which computes
the average ﬂuorescence intensity across the cells in the image (8 ). Indeed, individual cells
may express diﬀerent levels of ﬂuorescence due to biological noise, thus the choice of aver-
aging ﬂuorescence across the cells reduces the eﬀect of intrinsic and extrinsic noise sources
on the quantity to be controlled (ym).
The measured ﬂuorescence (ym) is then compared to the desired ﬂuorescence value (r),
and a control algorithm (controller) computes the necessary amount of inducer molecule u
to be administered to the cells in order to minimise the control error (e = r− ym), and then
moves the syringes accordingly.
In principle, the diﬀerence in hydrostatic pressure between the two syringes can be used
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to provide any desired concentration of the inducer molecule by mixing the two ﬂuids by
properly adjusting the heights of the two syringes. However, small errors in positioning
the syringes, which may be caused by the mechanical inaccuracies of motors, pulleys and
belts supporting them, may accumulate over time leading to large discrepancies between the
desired concentration of the molecule in the microﬂudic cell chamber and its actual value.
To overcome this problem, electrical motors with higher mechanical precision should be
employed. Therefore, in order to minimise the possibility of technical errors, we decided to
use a binary control input, that is, either no inducer is provided (i.e. just culture medium)
or a single predetermined concentration of the inducer molecule.
Figure 1
The experimental model.
As a test-bed for assessing the feasibility of automatically controlling gene expression in
mammalian cells, we chose the Tet-OFF system driving the expression of a destabilised yellow
ﬂuorescent reporter protein (d2EYFP) (9 ) in a monoclonal population of cells, as shown in
Figure 2a. In the Tet-OFF system, d2EYFP is expressed under the control of the CMT-TET
promoter(10 , 11 ) composed of a minimal CMV promoter with seven tet-responsive operator
motifs (tetO7 ), embedded in Chinese Hamster Ovary cells, constitutively expressing the
Tetracycline-transactivator (tTA) protein (Figure 2). The CMV-TET promoter is the most
commonly used and commercially available Tetracycline-responsive promoter engineered by
manufacturers to have a high transcriptional activity in mammalian cells.
In cells grown in standard growth medium, tTA protein is able to bind the CMV-TET
promoter causing d2EYFP to be maximally expressed. Upon addition of Tetracycline, or
Doxycycline, to the culture medium, tTA detaches from the CMV-TET promoter thus pre-
venting the expression of d2EYFP. This reporter protein has an half-life of 2 hours (8 ), which
represents a good trade-oﬀ between quantum yield and rapid turnover. A reporter with a
longer half-life could not have captured the dynamics of transcription, which occurs in a few
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hours, while a short-lived reporter would not have yielded a robust ﬂuorescence signal.
In the untreated population, ﬂuorescence is present in all cells at detectable levels (Figure
2b). The growth rate in the microﬂuidic device is similar to the one obtained in standard
culture dishes, and the ability of cells to express the ﬂuorescent reporter is not aﬀected under
perfused conditions (Figure S1).
The response of this monoclonal population to varying concentrations of Doxycycline
(from 1 ng/ml to 1 µg/ml) has been previously characterised (8 ). However, in our pre-
liminary experiments we observed an unexpected eﬀect of Doxycycline, i.e. the inability of
cells to re-express ﬂuorescence after Doxycycline washout (see Figure S2 and Supplemen-
tary Information for a discussion). This undesired eﬀect was greatly mitigated by the use of
Tetracycline, therefore we decided to use 100 ng/ml Tetracycline for our control experiments.
In order to assess whether automatic control of gene expression in mammalian cells was
feasible, we set as control task the set-point regulation depicted in Figure 1d: after an initial
calibration phase of 180 min, which is needed to quantify the initial level of ﬂuorescence,
cells are required to express 50% of their initial ﬂuorescence value for up to 3,500 min.
Figure 2
Control strategies: Relay and PI controllers
The choice of a control algorithm is a trade-oﬀ between robustness and accuracy: the ﬁrst
is the ability to control diﬀerent systems, albeit with a suboptimal performance; the latter
minimises the control error (e). Obtaining an optimal accuracy is usually possible only with
model-based control strategies. These approaches, however, require the identiﬁcation of a
mathematical model of the biological process being controlled, which may not always be
available or readily identiﬁable.
We decided, therefore, to test two model-independent control strategies: (i) the relay
controller, and (ii) the Proportional Integral controller.
The relay controller is the simplest type of model-independent control (12 ). It requires
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only the computation of the control error at each sampling time (kT ), where T=15 min,
whose sign dictates which input will be provided to the cells. Speciﬁcally, cells will be treated
with standard growing medium for the next 15 min, if e = (r − ym) ≥ 0, or Tetracycline-
containing medium otherwise (Methods and Supporting Information).
The drawback of this controller is that it does not take into account the dynamics of
the system, therefore it can be slow in converging to the desired set-point and show marked
oscillations around it. In addition, when the measured value ym is very close to the reference,
the control error can rapidly change sign, thus causing the control input to continuously
switch between the two growing media (a phenomenon known as "chattering"). To avoid
chattering, we added a 5% hysteresis interval to the controller (12 ), this corresponds to a
percentage tolerance interval around the set-point, in which the algorithm ignores the control
error value.
The Proportional-Integral (PI) controller is the most common technique used in practical
applications. It computes the control input as the sum of two components: one proportional
to the control error itself, and the other to its time integral (i.e. the past values of the
error) (12 ). The proportionality constants Kp and Ki are called respectively proportional
and integral gains, and their values were chosen by simple empirical rules (Methods and
Supporting Information) (12 ). The PI controller produces a control input which can as-
sume any positive or negative numerical value. However, cells can only be treated either
with Tetracycline or standard medium. To solve this problem, we applied a Pulse Width
Modulation (PWM) coding scheme. In PWM, at each sampling time, the control input is
converted to a pulse of Tetracycline (ON) whose duration is proportional to the control input
value. The Tetracycline pulse can vary from 0 min to 15 min (i.e. the sampling time), hence
0 min corresponds to the minimum control input value and 15 min to its maximum value.
(Methods and Supporting Information).
7
In silico set-point control of gene expression
We decided to test beforehand the performance of our controllers in silico. We have previ-
ously derived a dynamical model of the monoclonal cell-line harbouring the Tet-OFF sys-
tem used in this work(8 ). Therefore, we employed this model to simulate the dynamics of
d2EYFP in response to a time-varying input of Tetracycline (output). To simulate biological
variability, we added Gaussian noise to the simulation output.
Figure 3 shows the simulated level of ﬂuorescence in unstimulated conditions (Figure 3a),
or following sustained administration of Tetracycline (Figure 3b).
Figure 3c-d shows the simulation's result for the set-point control task when using the
relay controller and the PI controller, respectively. In both cases, as expected, oscillations
around the set-point are present. However, in the case of the PI controller, the amplitude of
the oscillations tends to diminish over time. Figure 3
The relay and PI controllers do not require a quantitative model of the experimental
system being controlled. The obvious advantage of this kind of control algorithms (i.e. no
model is required), however, is also a disadvantage in terms of their performances, as evi-
denced by the oscillations around the set-point. Without a quantitative model, these control
algorithms have no way to predict how gene expression will change in response to the in-
put (Tetracycline- or standard-medium). Oscillations around the set-point are caused by this
lack of predictive ability. On the contrary, if a quantitative model of the experimental system
is available, a model-based control strategy can be used to predict the level of ﬂuorescence
in response to the input, and thus compute the optimal sequence of Tetracycline/standard
medium pulses necessary to reach and maintain the desired ﬂuorescence level.
We performed an in silico simulation of a model-based control strategy (Model Predictive
Control) for the set-point control task. The results are shown in Supplementary Figure S3,
where it can be observed that oscillations have a much smaller amplitude, when compared to
the relay and PI controllers, and quickly dampen out. Of course, the control performance of
model-based control strategies is strictly dependent on the quality of the quantitative model
8
of the experimental system being controlled. Therefore in this work we decided not to test
this strategy experimentally.
In vitro set-point control of gene expression
The set-point control task, depicted in Figure 1d, was to reach and maintain a set point
equivalent to 50% of the ﬂuorescence value measured during the calibration phase. This
value is obtained by imaging cells in the absence of Tetracycline for 180 minutes at 15 min
intervals, and then calculating the time-averaged value of ﬂuorescence across the images.
Figure 4a-b shows the average level of ﬂuorescence in vitro in the cell population in
unstimulated conditions (Figure 3a), or following sustained administration of Tetracycline
(Figure 4b). In both cases results are quite comparable to the in silico simulations.
Figure 4c-d shows the results of the in vitro control experiments for both the relay and PI
controllers. As predicted in silico, the system is unable to settle on the reference value, but
it persistently oscillates around it for the whole length of the experiment (3500 min). The
behaviour of the relay controller (Figure 4c) is similar to the in silico simulation (Figure 3c),
exhibiting undamped oscillations around the set point. The time-lapse experiment reported
in Figure 4c is reported in the Supplementary Movie 1.
In the case of the PI controller in Figure 4d, oscillations have a decreasing amplitude
with time, as predicted in silico. One diﬀerence we observed, when compared to the corre-
sponding in silico simulations (Figure 3d), is the longer initial delay following Tetracycline
administration before ﬂuorescence starts to decrease. Nevertheless, the controller is able to
react accordingly, and the ﬂuorescence value of the cells is slowly brought towards the desired
set point. We believe that this slight diﬀerence in the initial dynamics is due to intrinsic
variabilities caused by experimental conditions and cell batches. The time-lapse experiment




Here, we presented a proof-of-principle study to demonstrate that microﬂuidics-based con-
trol of gene expression in mammalian cells is feasible. In order to do that, we chose two very
simple input-output control strategies (PI and Relay) that do not require a detailed quan-
titative model of gene expression. Oscillations around the set-point are to be expected when
using these controllers. For example, the Relay control algorithm checks at each sampling
time whether the ﬂuorescence has reached the desired value, if not then it will treat cells
either with Tetracycline, to reduce ﬂuorescence, or standard-medium, to increase it, for the
whole duration of the next sampling interval. This may cause ﬂuorescence to decrease (or
increase) too much, so that at the next sampling interval, its value will be below (or above)
the desired level, giving rise to oscillations around the set-point (Figure 4c-d). Oscillations
around the set-point are well documented in the control literature, for example in application
of bang-bang control (13 ), (14 ). This is an optimal control strategy to minimise the time
required for a physical system to achieve the desired set-point.
Control performances can be improved using a model-based control algorithms, such as
Model Predictive Control, in place of model-independent controllers used in this work, as
suggested by our in-silico results (Figure S3). Speciﬁcally, using these advanced controllers,
it might be possible to reduce or eliminate oscillations around the desired set-point and to
force cells to track a desired time-varying ﬂuorescence value.
Control of gene expression may be achieved also in a single cell, rather than in a cell pop-
ulation, thanks to the robustness to noise exhibited by feedback control strategies (12 ). In
yeast cells, for example, single-cell control has been successfully demonstrated (5 ). However
the major, but attainable, obstacle in the case of mammalian cells is the image segmentation
algorithm to track single cells over time. Due to the low optical density of the mammalian
cell membrane, diﬀerent cells are mistakenly merged together during image segmentation.
One way to solve the problem would be to mark the nucleus of the cells by an additional con-
stitutively expressed ﬂuorescent protein, in order to help the image segmentation algorithm
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to recognise individual cells.
Here we demonstrated that it is possible to regulate the expression of a reporter protein
from the Tetracycline-inducible promoter in a population of mammalian cells using principles
from automatic control engineering. To our knowledge, this is the ﬁrst time automated
control of gene expression from an inducible promoter has been achieved in mammalian
cells.
The Tet-OFF system used in this work is orthogonal to all other genes in mammalian
cells, has a very tight regulation and a high expression level (once induced) compared to
other inducible systems in mammalian cells (11 ). In addition, it requires a drug (Doxycy-
cline or Tetracycline) that is non-toxic and that can be administered systemically in mice
and humans. Hence, the Tetracycline-inducible promoter is widely used in thousands of
mammalian cell-lines, as well as animal models, in order to express a variety of trans-genes.
Therefore our platform could be quickly implemented in any research laboratory to study
already existing inducible cell lines, also derived from animal models, without the need of
an ad hoc design of a genetic circuit.
Methods
Cell culture procedures
Chinese Hamster Ovary (CHO) tetO7 -YFP cells(15 ) were maintained at 37 ◦C in a 5%
CO2-humidiﬁed incubator, and cultured in α-MEM (Sigma) supplemented with 10% heat-
inactivated TET system approved FBS (Life Technologies), 2 mM L-Glutamine and 100
U/ml Penicillin/Streptomycin (Gibco). Cells were passaged upon reaching of conﬂuence, by
rinsing the monolayer once with sterile ﬁltered Phosphate-Buﬀered Saline (PBS, Gibco) and
exposing cells to 0.25% Trypsin-EDTA for 1 minute. Cells are then resuspended and plated
at a density of 104 cells/cm2.
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Fluorescence time-lapse microscopy and control experiments
Image acquisition was performed using a Nikon Eclipse TI-E inverted epiﬂuorescence micro-
scope with a digital camera (Andor iXon897, Andor) and an incubation chamber (H201-OP
R2, Okolab), a 40× objective (Obj. PlanFluor DLL 40× Ph2, Nikon), a 20× objective (Obj.
CFI PF DLL 20× Ph1, Nikon), a TRITC HYQ ﬁlter (excitation 530 - 560 nm, emission
590 - 650 nm, Nikon) and a YELLOW GFP BP HYQ ﬁlter (excitation 490 - 510 nm, emis-
sion 520 - 550 nm, Nikon). Exposure time for experiments in chamber slides was set to 30
ms for the phase contrast images (with transmitted light lamp voltage was set to 3V), 300
ms for observation of d2EYFP, and 700 ms for observation of mCherry. Exposure time for
microﬂuidics experiments was set to 286 ms for the phase contrast images (with transmit-
ted light lamp voltage was set to 1.5V), 300 ms with EM gain set to 50 for observation of
d2EYFP and Sulforhodamine tracker. Images were acquired every 15 minutes for all the
experiments. Images were processed via a custom-made segmentation algorithm to quantify
the average ﬂuorescence expressed by the cell population(15 ). Temperature was maintained
constantly at 37◦C, and CO2 concentration was set to 5% of the total air volume injected
in the incubation chamber. Experiments were performed and images were extracted using
the NIS-Elements AR v.3.22.14 software package and the Perfect Focus System (Nikon In-
struments) to maintain the focal plane throughout the experiment. At the beginning of each
experiment, cells were allowed to grow in untreated medium for three hours, to rule out
any ﬂuctuation in metabolism due to displacement of the device from the cell incubator to
the incubation chamber of the microscope. Cells were then switched to Tetracycline-treated
medium at the indicated concentrations for diﬀerent time intervals. We quantiﬁed the mean
ﬂuorescence for each group of cells in a trap, and in order to rule out cell-to-cell variability,
and we plotted the mean and standard deviation among all traps (i.e. replicates) for each
experiment. For control experiments, tetO7 -YFP cells were loaded into the microﬂuidic
device as described in the Supplementary Information, where microﬂudics device's fabrica-
tion is also detailed. For calibration experiments, the timing of the exposure to the drug
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(either Doxycycline or Tetracycline, according to the speciﬁc experiment) was set a priori.
Each control experiments began with an initial calibration phase of 180 minutes in untreated
medium. After the calibration phase the control experiment being and the duration of the
exposure of the cells to Tetracycline was computed at each time point by the control algo-
rithm (relay or PI). Fluorescence quantiﬁcation was automatically performed in real time by
a segmentation algorithm implemented in Matlab2010b, based on the one already published
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Microﬂuidic device fabrication protocol and control algorithms (PI, Relay, MPC).
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Acknowledgements
We thank Prof. Jeﬀ Hasty and his lab for providing the design of the microﬂuidic device
and details on how to use it.
13
Funding sources
This work was supported by a Human Frontier Science Program HFSP RGP0020/2011 to
DdB and by the Italian Fondazione Telethon.
14
Figures Legends
Figure 1: Control platform and control algorithms. (a) Cells are grown in a microﬂuidic
device within a temperature- and CO2-controlled environment under an inverted ﬂuorescence
microscope. Images are acquired every 15 minutes (y), and quantiﬁcation of ﬂuorescence is
performed via an image-segmentation algorithm. The measured level of ﬂuorescence (ym) is
compared to the desired reference value (r). The control algorithm computes the input u
to be provided to the cells and moves the syringes containing either untreated medium or
Tetracycline-treated medium. (b) Block scheme of a Relay controller. The output from the
system (Plant) is subtracted to the reference to obtain the error e; the error is processed by
the Relay into a binary input u. (c) Block scheme of a PI-PWM controller. The error is
calculated as in b, the control input uˆ is proportional to the control error and to its time-
integral, a Pulse Width Modulation block is used to transform uˆ into a binary input u. (d)
Schematic representation of the control task. The high steady state of ﬂuorescence (black
line) is calculated by averaging the ﬁrst 180 minutes of acquisition (calibration phase), then
the reference (blue line) is calculated as 50% of the high steady state; the control task is to
keep the measured level of ﬂuorescence on the reference for 3500 minutes.
Figure 2: The experimental model: tetO7 -YFP monoclonal cell line. (a) The Tetra-
cycline transactivator (tTA) is constitutively expressed by a CMV promoter. The tTA binds
the CMVTET promoter harbouring seven Tet Responsive Elements (tetO7 ) upstream of a
minimal CMV promoter, thus driving the transcription of a destabilised EYFP (d2EYFP).
Doxycycline, or Tetracycline, bind the tTA protein and prevent its binding to the CMVTET
promoter. (b) Representative phase contrast (left panel) and ﬂuorescence (right panel) im-
ages of tetO7 -YFP cells in a microﬂuidic device grown in the absence of Tetracycline.
Figure 3: In silico set-point control experiments. The red line under each graph rep-
resents the respective Tetracycline input simulated. The green line represents the simulated
ﬂuorescence output. (a) Simulation of the model when no Tetracycline is provided to cells.
(b) Simulation of the model when a saturating concentration of Tetracycline is applied to the
cells. (c,d) Simulations of the Relay (c) and PI (d) control algorithms when the reference
set-point value (cyan line) is equal to 50% of the ﬂuorescence level exhibited by cells in the
absence of Tetracycline.
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Figure 4: In vitro set-point control experiments. The red line under each graph
represents the respective Tetracycline input provided to cells in the microﬂuidic device.
The green line represents the measured mean ﬂuorescence of the imaged ﬁelds (mean and
standard deviation of 3 to 8 replicates). (a) Fluorescence exhibited by the cells in the
presence of growing medium with no Tetracycline. (b) Fluorescence exhibited by the cells
in the presence of 100ng/ml Tetracycline in the growing medium. (c,d) Results of the
Relay (c) and PI (c) control experiments for the set-point control task (cyan line) where the
desired ﬂuorescence is equal to 50% of the initial ﬂuorescence exhibited by cells during the
calibration phase of 180 min.
References
1. Grodins, F. S., Gray, J. S., Schroeder, K. R., Norins, A. L., and Jones, R. W. (1954)
Respiratory responses to CO2 inhalation. A theoretical study of a nonlinear biological
regulator. Journal of applied physiology 7, 283308.
2. Milias-Argeitis, A., Summers, S., Stewart-Ornstein, J., Zuleta, I., Pincus, D., El-
Samad, H., Khammash, M., and Lygeros, J. (2011) In silico feedback for in vivo regula-
tion of a gene expression circuit. Nature biotechnology 29, 11146.
3. Ulhendorf, J., Miermont, A., Delaveau, T., Chavrin, G., Fages, F., Bottani, S., Batt, G.,
and Hersen, P. (2012) Long-term model predictive control of gene expression at the
population and single-cell levels. PNAS 109, 142716.
4. Menolascina, F., Fiore, G., Orabona, E., De Stefano, L., Ferry, M., Hasty, J.,
di Bernardo, M., and di Bernardo, D. (2014) In-vivo real-time control of protein ex-
pression from endogenous and synthetic gene networks. PLoS computational biology 10,
e1003625.
5. Toettcher, J. E., Gong, D., Lim, W. a., and Weiner, O. D. (2011) Light-based feedback
for controlling intracellular signaling dynamics. Nature methods 8, 8379.
6. Darzacq, X., Shav-Tal, Y., de Turris, V., Brody, Y., Shenoy, S. M., Phair, R. D., and
16
Singer, R. H. (2007) In vivo dynamics of RNA polymerase II transcription. Nature struc-
tural & molecular biology 14, 796806.
7. Kolnik, M., Tsimring, L. S., and Hasty, J. (2012) Vacuum-assisted cell loading enables
shear-free mammalian microﬂuidic culture. Lab on a chip
8. Siciliano, V., Menolascina, F., Marucci, L., Fracassi, C., Garzilli, I., Moretti, M. N.,
and di Bernardo, D. (2011) Construction and Modelling of an Inducible Positive Feed-
back Loop Stably Integrated in a Mammalian Cell-Line. PLoS Computational Biology
7, e1002074.
9. Tigges, M., Marquez-Lago, T. T., Stelling, J., and Fussenegger, M. (2009) A tunable
synthetic mammalian oscillator. Nature 457, 30912.
10. Gossen, M., and Bujard, H. (1992) Tight control of gene expression in mammalian cells
by tetracycline-responsive promoters. Proceedings of the National Academy of Sciences
of the United States of America 89, 554751.
11. Gossen, M., Bonin, a. L., Freundlieb, S., and Bujard, H. (1994) Inducible gene expression
systems for higher eukaryotic cells. Current opinion in biotechnology 5, 516520.
12. Å ström, K. J., and Richard, M. M. America; Princeton university press, 2010.
13. TSypkin, I. Z. Relay control systems ; CUP Archive, 1984.
14. Hirata, Y., di Bernardo, M., Bruchovsky, N., and Aihara, K. (2010) Hybrid optimal
scheduling for intermittent androgen suppression of prostate cancer. Chaos: An Inter-
disciplinary Journal of Nonlinear Science 20, 045125.
15. Siciliano, V., Garzilli, I., Fracassi, C., Criscuolo, S., Ventre, S., and di Bernardo, D. (2013)
MiRNAs confer phenotypic robustness to gene networks by suppressing biological noise.
Nature communications 4, 2364.
17
